Analysts: Disney Will Continue Outperformance and 3 More Research Notes to Explore

Walt Disney Co. (NYSE:DIS): Credit Suisse continues to expect Disney to be a relative outperformer, driven largely by its EPSN affiliate revenue cycle, the Lucasfilm acquisition, My Magic+ product, and Shanghai Disney. The firm rates the stock at Outperform with a $74 price target, up from $73.


Intuitive Surgical (NASDAQ:ISRG): Lazard Capital believes a slowdown in hysterectomies will drive Intuitive Surgical’s procedure growth in the second quarter to miss the consensus estimate of 18.4 percent. The firm’s models signal 15.9 percent growth in the quarter, and Lazard believes that investors could buy shares at a lower price after the results. Lazard Capital keeps a Buy rating on Intuitive Surgical shares with a $625 price target.


Oracle Corp. (NASDAQ:ORCL): Lazard Capital finds that Oracle’s recurring revenue stream is worth at least 10 percent more than the current share price, and sees limited share downside from current levels while investor sentiment may be overly negative. Lazard has a Buy rating on the stock with a $38 price target.


BP PLC (NYSE:BP): ISI Group has downgraded BP to Neutral from Buy, stating that clarity on the final Macondo settlement remains “elusive” and the investment case continues to be pushed out.


Don’t Miss: Did The Lone Ranger’s Failure Endanger Future Films?